As STAT3 has been established as a key player in many types of cancer, a novel STAT3 ASO, known as AZD9150, is currently undergoing clinical investigation for the treatment of lymphoma and lung cancer [69]. The gene discussed is STAT3; the disease is lung carcinoma.